ANTH
Vanguard Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-446,972
| Closed | -$143K | – | 4145 |
|
|
2018
Q1 | $143K | Buy |
446,972
+137,083
| +44% | +$43.9K | ﹤0.01% | 3998 |
|
|
2017
Q4 | $512K | Sell |
309,889
-49,862
| -14% | -$82.4K | ﹤0.01% | 3743 |
|
|
2017
Q3 | $518K | Buy |
359,751
+18,750
| +5% | +$27K | ﹤0.01% | 3744 |
|
|
2017
Q2 | $553K | Sell |
341,001
-2,350,638
| -87% | -$3.81M | ﹤0.01% | 3706 |
|
|
2017
Q1 | $1.15M | Buy |
2,691,639
+886,910
| +49% | +$377K | ﹤0.01% | 3542 |
|
|
2016
Q4 | $1.17M | Buy |
1,804,729
+246,174
| +16% | +$160K | ﹤0.01% | 3513 |
|
|
2016
Q3 | $4.91M | Buy |
1,558,555
+75,751
| +5% | +$239K | ﹤0.01% | 3024 |
|
|
2016
Q2 | $4.58M | Buy |
1,482,804
+47,288
| +3% | +$146K | ﹤0.01% | 3032 |
|
|
2016
Q1 | $5.2M | Buy |
1,435,516
+102,797
| +8% | +$372K | ﹤0.01% | 2941 |
|
|
2015
Q4 | $6.18M | Buy |
1,332,719
+55,230
| +4% | +$256K | ﹤0.01% | 2892 |
|
|
2015
Q3 | $7.78M | Buy |
1,277,489
+157,527
| +14% | +$959K | ﹤0.01% | 2735 |
|
|
2015
Q2 | $9.65M | Buy |
1,119,962
+65,482
| +6% | +$564K | ﹤0.01% | 2687 |
|
|
2015
Q1 | $4.71M | Buy |
1,054,480
+503,986
| +92% | +$2.25M | ﹤0.01% | 3026 |
|
|
2014
Q4 | $869K | Buy |
550,494
+20,900
| +4% | +$33K | ﹤0.01% | 3572 |
|
|
2014
Q3 | $1.02M | Buy |
529,594
+58,648
| +12% | +$113K | ﹤0.01% | 3502 |
|
|
2014
Q2 | $1.6M | Buy |
470,946
+42,900
| +10% | +$145K | ﹤0.01% | 3348 |
|
|
2014
Q1 | $1.43M | Buy |
428,046
+92,254
| +27% | +$309K | ﹤0.01% | 3344 |
|
|
2013
Q4 | $1.03M | Sell |
335,792
-13,832
| -4% | -$42.5K | ﹤0.01% | 3406 |
|
|
2013
Q3 | $1.41M | Sell |
349,624
-2,440,986
| -87% | -$9.82M | ﹤0.01% | 3270 |
|
|
2013
Q2 | $1.29M | Buy |
+2,790,610
| New | +$1.29M | ﹤0.01% | 3230 |
|